• P Schultz, J-B Morvan, N Fakhry, S Morinière, S Vergez, C Lacroix, S Bartier, B Barry, E Babin, V Couloigner, I Atallah, French Society of Otorhinolaryngology, Head, Neck Surgery (SFORL), and French Society of Head, Neck Carcinology (SFCCF).
• Service d'ORL et de chirurgie cervico-faciale, hôpital de Hautepierre, avenue Molière, 67098 Strasbourg, France. Electronic address: philippe.schultz@chru-strasbourg.fr.
• Eur Ann Otorhinolaryngol Head Neck Dis. 2020 May 1; 137 (3): 167-169.

AbstractTracheostomy post-tracheostomy care are regarded as at high risk for contamination of health care professionals with the new coronavirus (SARS-CoV-2). Considering the rapid spread of the infection, all patients in France must be considered as potentially infected by the virus. Nevertheless, patients without clinical or radiological (CT scan) markers of COVID-19, and with negative nasopharyngeal sample within 24h of surgery, are at low risk of being infected. Instructions for personal protection include specific wound dressings and decontamination of all material used. The operating room should be ventilated after each tracheostomy and the pressure of the room should be neutral or negative. Percutaneous tracheostomy is to be preferred over surgical cervicotomy in order to reduce aerosolization and to avoid moving patients from the intensive care unit to the operating room. Ventilation must be optimized during the procedure, to limit patient oxygen desaturation. Drug assisted neuromuscular blockage is advised to reduce coughing during tracheostomy tube insertion. An experienced team is mandatory to secure and accelerate the procedure as well as to reduce risk of contamination.Copyright © 2020. Published by Elsevier Masson SAS.

40 keywords...

hide…